Who owns INMED PHARMACEUTICALS INC?
- Ticker: INM
- CUSIP Number: 457637601
Tip: Access positions for across all investors
Analyze quarterly positions in Inmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inmed Pharmaceuticals stock
Who bought or sold INMED PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 34k | $14k | 100% | Dec 2023 |
|
| Two Sigma Securities | 13k | $5.4k | 100% | Dec 2023 |
|
| Bank of America Corporation | 100.00 | $42.000000 | 100% | Dec 2023 |
|
| TD Waterhouse Canada | 85.00 | $43.001500 | 0% | Dec 2023 |
|
| AdvisorNet Financial | 80.00 | $29.000000 | 100% | Mar 2024 |
|
| Advisory Services Network | 59.00 | $24.998300 | 100% | Dec 2023 |
|
| Advisor Group Holdings | 41.00 | $13.665300 | -33% | Dec 2023 |
|
| AllSquare Wealth Management | 21.00 | $9.000600 | 0% | Dec 2023 |
|
| National Bank Of Canada /fi/ | 12.00 | $5.000400 | -40% | Dec 2023 |
|
| Royal Bank of Canada | 11.00 | $0 | -58% | Dec 2023 |
|
| Global Retirement Partners | 6.00 | $1.999800 | 100% | Dec 2023 |
|
| Gables Capital Management | 1.00 | $0 | 0% | Dec 2023 |
|
Who sold out of Inmed Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Sep 2023 | 69.00 | $48.003300 |